Open AccessThis article is
- freely available
Antiviral Activity of 4'-thioIDU and Thymidine Analogs against Orthopoxviruses
Department of Pediatrics, University of Alabama School of Medicine, CHB 128, 1600 6th Ave S, Birmingham AL 35233-1711, USA
* Author to whom correspondence should be addressed.
Received: 5 August 2010; in revised form: 20 August 2010 / Accepted: 7 September 2010 / Published: 16 September 2010
Abstract: The search for effective therapies for orthopoxvirus infections has identified diverse classes of molecules with antiviral activity. Pyrimidine analogs, such as 5-iodo-2'-deoxyuridine (idoxuridine, IDU) were among the first compounds identified with antiviral activity against a number of orthopoxviruses and have been reported to be active both in vitro and in animal models of infection. More recently, additional analogs have been reported to have improved antiviral activity against orthopoxviruses including several derivatives of deoxyuridine with large substituents in the 5 position, as well as analogs with modifications in the deoxyribose moiety including (north)-methanocarbathymidine, and 5-iodo-4'-thio-2'-deoxyuridine (4'-thioIDU). The latter molecule has proven to have good antiviral activity against the orthopoxviruses both in vitro and in vivo and has the potential to be an effective therapy in humans.
Keywords: orthopoxvirus; antiviral; nucleoside; pyrimidine; idoxuridine; deoxyuridine; 4'-thioIDU
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Prichard, M.N.; Kern, E.R. Antiviral Activity of 4'-thioIDU and Thymidine Analogs against Orthopoxviruses. Viruses 2010, 2, 1968-1983.
Prichard MN, Kern ER. Antiviral Activity of 4'-thioIDU and Thymidine Analogs against Orthopoxviruses. Viruses. 2010; 2(9):1968-1983.
Prichard, Mark N.; Kern, Earl R. 2010. "Antiviral Activity of 4'-thioIDU and Thymidine Analogs against Orthopoxviruses." Viruses 2, no. 9: 1968-1983.